1. Home
  2. PJT vs BHVN Comparison

PJT vs BHVN Comparison

Compare PJT & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PJT
  • BHVN
  • Stock Information
  • Founded
  • PJT 2014
  • BHVN 2013
  • Country
  • PJT United States
  • BHVN United States
  • Employees
  • PJT 1012
  • BHVN N/A
  • Industry
  • PJT Investment Managers
  • BHVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • PJT Finance
  • BHVN Health Care
  • Exchange
  • PJT Nasdaq
  • BHVN Nasdaq
  • Market Cap
  • PJT 3.8B
  • BHVN 5.4B
  • IPO Year
  • PJT N/A
  • BHVN 2017
  • Fundamental
  • Price
  • PJT $159.13
  • BHVN $53.44
  • Analyst Decision
  • PJT Hold
  • BHVN Strong Buy
  • Analyst Count
  • PJT 8
  • BHVN 13
  • Target Price
  • PJT $119.29
  • BHVN $61.92
  • AVG Volume (30 Days)
  • PJT 246.5K
  • BHVN 708.1K
  • Earning Date
  • PJT 10-29-2024
  • BHVN 11-19-2024
  • Dividend Yield
  • PJT 0.63%
  • BHVN N/A
  • EPS Growth
  • PJT 20.14
  • BHVN N/A
  • EPS
  • PJT 3.78
  • BHVN N/A
  • Revenue
  • PJT $1,345,850,000.00
  • BHVN N/A
  • Revenue This Year
  • PJT $21.99
  • BHVN N/A
  • Revenue Next Year
  • PJT $12.69
  • BHVN $179.00
  • P/E Ratio
  • PJT $42.16
  • BHVN N/A
  • Revenue Growth
  • PJT 21.75
  • BHVN N/A
  • 52 Week Low
  • PJT $81.26
  • BHVN $26.80
  • 52 Week High
  • PJT $163.54
  • BHVN $62.21
  • Technical
  • Relative Strength Index (RSI)
  • PJT 70.73
  • BHVN 60.08
  • Support Level
  • PJT $137.03
  • BHVN $48.76
  • Resistance Level
  • PJT $163.54
  • BHVN $54.98
  • Average True Range (ATR)
  • PJT 4.17
  • BHVN 2.10
  • MACD
  • PJT 1.57
  • BHVN -0.15
  • Stochastic Oscillator
  • PJT 85.88
  • BHVN 75.26

About PJT PJT Partners Inc.

PJT Partners Inc is an advisory-focused investment bank that offers a portfolio of advisory services designed to help its clients achieve their strategic objectives. The company delivers a range of strategic advisory, capital markets advisory, restructuring and special situations, and shareholder advisory services to corporations, financial sponsors, institutional investors, and governments around the world. It also provides private fund advisory and fundraising services for alternative investment strategies, including private equity, real estate, hedge funds, and private credit. The company generates its revenue from advisory fees, placement fees, and others. Geographically, It generates a majority of its revenue from the United States.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: